Multicenter phase II study of neoadjuvant chemotherapy consisted with S-1 and oxaliplatin followed by gastrectomy for locally advanced gastric cancer.

Authors

Yoshihiro Okita

Yoshihiro Okita

Department of Clinical Oncology, Kagawa University Faculty of Medicine, Kagawa, Japan

Yoshihiro Okita , Hironaga Satake , Hiroyuki Okuyama , Masato Kondo , Akira Miki , Takanori Watanabe , Yukimasa Hatachi , Masahito Kotaka , Shigeyoshi Iwamoto , Takeshi Kato , Akihito Tsuji

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

UMIN000018661

Citation

J Clin Oncol 34, 2016 (suppl 4S; abstr TPS180)

DOI

10.1200/jco.2016.34.4_suppl.tps180

Abstract #

TPS180

Poster Bd #

O6

Abstract Disclosures

Similar Posters

First Author: Masato Kondo

Poster

2017 Gastrointestinal Cancers Symposium

Phase I study of neoadjuvant chemotherapy with xeloda and oxaliplatin (G-XELOX) for locally advanced gastric cancer.

Phase I study of neoadjuvant chemotherapy with xeloda and oxaliplatin (G-XELOX) for locally advanced gastric cancer.

First Author: Hironaga Satake

First Author: Rixci Ramirez